ST6GAL1 anticorps

N° du produit ABIN7865739

L’anticorps anti-ST6GAL1 Monoclonal Souris est utilisé pour la détection de ST6GAL1 dans des échantillons de Humain. Il a été validé pour IHC, FACS, IF et ICC.

Aperçu rapide pour ST6GAL1 anticorps (ABIN7865739)

Antigène: ST6GAL1 (ST6 beta-Galactosamide alpha-2,6-Sialyltranferase 1 (ST6GAL1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ST6GAL1 est non-conjugé

Application: Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone: LN-1

Détail du produit anti-ST6GAL1 anticorps

Fonction: anti-CDw75 mouse monoclonal, LN-1, purified

Purification: affinity chromatography

Immunogène: nuclei from pokeweed mitrogen-stimulated PBL

Isotype: IgM kappa

Information d'application

Indications d'application:

ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)

FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml

IHC-paraffin_dilution: 1:50-1:100 (1-2 μg/mL, microwave treatment in 10 mM citrate buffer pH 6.0 recommended)

IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 100 μg/mL

Buffer: PBS with 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: store at 2 - 8 °C

Détails sur ST6GAL1

Antigène: ST6GAL1 (ST6 beta-Galactosamide alpha-2,6-Sialyltranferase 1 (ST6GAL1))

Autre désignation: CDw75

Sujet: LN-1 reacts with CDw75, a neuraminidase sensitive cell surface sialoglycan which is present on the cell membrane and cytoplasm of germininal center B-cells and derived lymphomas. CDw75 has a function in cell adhesion and is the ligand for CD22. LN-1 reacts with RBC precursors in bone marrow, ductal and ciliated epithelial cells of kidney, breast, prostate, pancreas, lung, and with gioblastomas and astrocytoma’s, and also Reed Sternberg cells in Hodgkin’s disease. Positive control: HeLa or Daudi cells. Germinal center B-cell in a lymph node or tonsil. Use LN-1’s ability to stain the surface of erythrocytes as an internal positive control.